Brought to you by 
Ardana Bioscience acquires Zentaris's Europeptides
09 Sep 2020
Executive Summary
Ardana Bioscience (reproductive health pharmaceuticals) bought Zentaris's R&D unit Europeptides for a total of Euro28mm ($27.7mm)--$6.2mm up front and $21.5mm in future earn-outs. Zentaris will also receive royalties.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ardana Bioscience acquires Zentaris's Europeptides
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice